La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic

Virology

Volumn 404, Issue 2, 2010, Pages 139-147

  Soldan, Samantha S ^a   Hollidge, Bradley S ^a   Wagner, Valentina ^b   Weber, Friedemann ^b   González Scarano, Francisco ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bunyaviridae; Fusion; Glycoprotein; La Crosse virus; Neuropathogenesis; Pathogenesis; Recombinant virus

Indexed keywords

GLYCOPROTEIN GC; PEPTIDE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; LA CROSSE VIRUS; NERVE CELL CULTURE; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; VIROGENESIS; VIRUS ENTRY; VIRUS MUTANT; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; CELL LINE; CRICETINAE; FIBROBLASTS; LA CROSSE VIRUS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHENOTYPE; VIRAL FUSION PROTEINS; VIRUS REPLICATION;

EID: 77954537038     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.04.012     Document Type: Article

References (35)

1. Blakqori G., Weber F. Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J. Virol. 2005, 79(16):10420-10428.
2. Blakqori G., Kochs G., Haller O., Weber F. Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids. J. Gen. Virol. 2003, 84(Pt 5):1207-1214.
3. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 1995, 42(5):674-683.
4. Buchholz U.J., Finke S., Conzelmann K.K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 1999, 73(1):251-259.
5. Bupp K., Stillmock K., Gonzalez-Scarano F. Analysis of the intracellular transport properties of recombinant La Crosse virus glycoproteins. Virology 1996, 220(2):485-490.
6. Endres M.J., Jacoby D.R., Janssen R.S., Gonzalez-Scarano F., Nathanson N. The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. J. Gen. Virol. 1989, 70(Pt 1):223-228.
7. Eshita Y., Ericson B., Romanowski V., Bishop D.H. Analyses of the mRNA transcription processes of snowshoe hare bunyavirus S and M RNA species. J. Virol. 1985, 55(3):681-689.
8. Fazakerley J.K., Gonzalez-Scarano F., Strickler J., Dietzschold B., Karush F., Nathanson N. Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology 1988, 167(2):422-432.
9. Garry C.E., Garry R.F. Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes). Theor. Biol. Med. Model. 2004, 1:10.
10. Gentsch J.R., Bishop D.L. M viral RNA segment of bunyaviruses codes for two glycoproteins, G1 and G2. J. Virol. 1979, 30(3):767-770.
11. Gonzalez-Scarano F. La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion. Virology 1985, 140(2):209-216.
12. Gonzalez-Scarano F., Shope R.E., Calisher C.E., Nathanson N. Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology 1982, 120(1):42-53.
13. Gonzalez-Scarano F., Pobjecky N., Nathanson N. La Crosse bunyavirus can mediate pH-dependent fusion from without. Virology 1984, 132(1):222-225.
14. Gonzalez-Scarano F., Janssen R.S., Najjar J.A., Pobjecky N., Nathanson N. An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function. J. Virol. 1985, 54(3):757-763.
15. Griot C., Pekosz A., Lukac D., Scherer S.S., Stillmock K., Schmeidler D., Endres M.J., Gonzalez-Scarano F., Nathanson N. Polygenic control of neuroinvasiveness in California serogroup bunyaviruses. J. Virol. 1993, 67(7):3861-3867.
16. Griot C., Pekosz A., Davidson R., Stillmock K., Hoek M., Lukac D., Schmeidler D., Cobbinah I., Gonzalez-Scarano F., Nathanson N. Replication in cultured C2C12 muscle cells correlates with the neuroinvasiveness of California serogroup bunyaviruses. Virology 1994, 201(2):399-403.
17. Habjan M., Penski N., Wagner V., Spiegel M., Overby A.K., Kochs G., Huiskonen J.T., Weber F. Efficient production of Rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology 2009, 385(2):400-408.
18. Janssen R., Gonzalez-Scarano F., Nathanson N. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab. Invest. 1984, 50(4):447-455.
19. Janssen R.S., Nathanson N., Endres M.J., Gonzalez-Scarano F. Virulence of La Crosse virus is under polygenic control. J. Virol. 1986, 59(1):1-7.
20. Kalfayan B. Pathology of La Crosse virus infection in humans. California Serogroup Viruses 1983, 179-186. Liss, New York. C.H. Calisher, W.H. Thompso (Eds.).
21. Lappin D.F., Nakitare G.W., Palfreyman J.W., Elliott R.M. Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSm. J. Gen. Virol. 1994, 75(Pt 12):3441-3451.
22. Levy-Mintz P., Kielian M. Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein. J. Virol. 1991, 65(8):4292-4300.
23. Ma M., Kersten D.B., Kamrud K.I., Wool-Lewis R.J., Schmaljohn C., Gonzalez-Scarano F. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism. Virus Res. 1999, 64(1):23-32.
24. McJunkin J.E., Khan R.R., Tsai T.F. California-La Crosse encephalitis. Infect. Dis. Clin. North Am. 1998, 12(1):83-93.
25. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108(2):193-199.
26. O'Donnell L.A., Agrawal A., Jordan-Sciutto K.L., Dichter M.A., Lynch D.R., Kolson D.L. Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. J. Neurosci. 2006, 26(3):981-990.
27. Pekosz A., Griot C., Nathanson N., Gonzalez-Scarano F. Tropism of bunyaviruses: evidence for a G1 glycoprotein-mediated entry pathway common to the California serogroup. Virology 1995, 214(2):339-348.
28. Pekosz A., Griot C., Stillmock K., Nathanson N., Gonzalez-Scarano F. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J. Virol. 1995, 69(6):3475-3481.
29. Plassmeyer M.L., Soldan S.S., Stachelek K.M., Martin-Garcia J., Gonzalez-Scarano F. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry. Virology 2005, 338(1):121-132.
30. Plassmeyer M.L., Soldan S.S., Stachelek K.M., Roth S.M., Martin-Garcia J., Gonzalez-Scarano F. Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide. Virology 2007, 358(2):273-282.
31. Pobjecky N., Smith J., Gonzalez-Scarano F. Biological studies of the fusion function of California serogroup Bunyaviruses. Microb. Pathog. 1986, 1(5):491-501.
32. Ruusala A., Persson R., Schmaljohn C.S., Pettersson R.F. Coexpression of the membrane glycoproteins G1 and G2 of Hantaan virus is required for targeting to the Golgi complex. Virology 1992, 186(1):53-64.
33. Sundin D.R., Beaty B.J., Nathanson N., Gonzalez-Scarano F. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus. Science 1987, 235(4788):591-593.
34. Thompson W.H., Kalfayan B., Anslow R.O. Isolation of California encephalitis group virus from a fatal human illness. Am. J. Epidemiol. 1965, 81:245-253.
35. Wang Y., White M.G., Akay C., Chodroff R.A., Robinson J., Lindl K.A., Dichter M.A., Qian Y., Mao Z., Kolson D.L., Jordan-Sciutto K.L. Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. J. Neurochem. 2007, 103(2):439-455.